ArticleCancer research communications2025

The ATR Inhibitor Elimusertib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A California Cancer Consortium Phase I Trial (NCI 10404).

Mamta Parikh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.